IO Biotech, Inc. (IOBT) Tops Q2 EPS by 3c

IO Biotech, Inc. (NASDAQ: IOBT) reported Q2 EPS of ($0.31), $0.03 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on IO Biotech, Inc. (IOBT) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Meta pauses an AI training program that tracks employees' keystrokes after a companywide leak - Insider
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval